|
SA2640B1
|
|
Compounds of Cannabinoid-CB1 Antagonists and Structural Components of the Serotonin Reuptake Inhibitors Indalpine or Fluvoxamine
|
|
SA2637B1
|
|
Azaindole Derivatives with a Combination of Partial Nicotinic Acetyl-Choline Receptor Agonism and Dopamine Reuptake Inhibition
|
|
SA2500B1
|
|
Combination Preparations Comprising Bifeprunox and L-Dopa
|
|
SA2444B1
|
|
Oral Composition of Benzazepin-1-Acetic Acid Derivatives Comprising an Alkaline and Optionally Auxiliary Materials
|
|
SA2436B1
|
|
Sulphur Containing Pyrazole Derivatives as Selective Cannabinoid CB1 Receptor Antagonists
|
|
SA2794B1
|
|
1h- imidazole derivatives as cannabinoid cb2 receptor modulators
|
|
SA2191B1
|
|
Hexa-and octahydro-pyrido[1,2-a] pyrazine derivatives with NK1 antagonistic activity
|
